Evonik Industries (EVK) Given a €32.00 Price Target by Kepler Capital Markets Analysts
Evonik Industries (FRA:EVK) has been given a €32.00 ($37.21) price objective by equities researchers at Kepler Capital Markets in a note issued to investors on Tuesday. The brokerage currently has a “neutral” rating on the stock. Kepler Capital Markets’ price objective indicates a potential upside of 1.27% from the stock’s current price.
A number of other equities analysts also recently commented on the company. Baader Bank set a €40.00 ($46.51) price objective on Evonik Industries and gave the stock a “buy” rating in a report on Monday, July 30th. Nord/LB set a €32.00 ($37.21) price objective on Evonik Industries and gave the stock a “neutral” rating in a report on Tuesday, May 29th. Societe Generale set a €40.00 ($46.51) price objective on Evonik Industries and gave the stock a “buy” rating in a report on Monday, August 13th. UBS Group set a €29.00 ($33.72) price objective on Evonik Industries and gave the stock a “sell” rating in a report on Monday, August 20th. Finally, Berenberg Bank set a €38.00 ($44.19) price objective on Evonik Industries and gave the stock a “buy” rating in a report on Friday, August 3rd. Four research analysts have rated the stock with a sell rating, six have assigned a hold rating and twelve have given a buy rating to the company’s stock. Evonik Industries has an average rating of “Hold” and a consensus price target of €34.80 ($40.47).
FRA:EVK opened at €31.60 ($36.74) on Tuesday. Evonik Industries has a 52 week low of €26.78 ($31.14) and a 52 week high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
See Also: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.